Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Other Non-Current Liabilities (2020)

Historic Other Non-Current Liabilities for Tango Therapeutics (TNGX) over the last 1 years, with Q4 2020 value amounting to $5000.0.

  • Tango Therapeutics' Other Non-Current Liabilities changed N/A to $5000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $5000.0, marking a year-over-year change of. This contributed to the annual value of $5000.0 for FY2020, which is N/A changed from last year.
  • Per Tango Therapeutics' latest filing, its Other Non-Current Liabilities stood at $5000.0 for Q4 2020.
  • Tango Therapeutics' Other Non-Current Liabilities' 5-year high stood at $5000.0 during Q4 2020, with a 5-year trough of $5000.0 in Q4 2020.